CA2346086A1 - Composition for treatment of light-injured retinal degeneration disease - Google Patents

Composition for treatment of light-injured retinal degeneration disease Download PDF

Info

Publication number
CA2346086A1
CA2346086A1 CA002346086A CA2346086A CA2346086A1 CA 2346086 A1 CA2346086 A1 CA 2346086A1 CA 002346086 A CA002346086 A CA 002346086A CA 2346086 A CA2346086 A CA 2346086A CA 2346086 A1 CA2346086 A1 CA 2346086A1
Authority
CA
Canada
Prior art keywords
light
treatment
retinal degeneration
lower alkyl
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002346086A
Other languages
English (en)
French (fr)
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2346086A1 publication Critical patent/CA2346086A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CA002346086A 1998-10-02 1999-09-29 Composition for treatment of light-injured retinal degeneration disease Abandoned CA2346086A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10297298P 1998-10-02 1998-10-02
US60/102,972 1998-10-02
US11070098P 1998-12-03 1998-12-03
US60/110,700 1998-12-03
PCT/JP1999/005321 WO2000020002A1 (en) 1998-10-02 1999-09-29 Composition for treatment of light-injured retinal degeneration disease

Publications (1)

Publication Number Publication Date
CA2346086A1 true CA2346086A1 (en) 2000-04-13

Family

ID=26799937

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002346086A Abandoned CA2346086A1 (en) 1998-10-02 1999-09-29 Composition for treatment of light-injured retinal degeneration disease

Country Status (8)

Country Link
US (1) US6248759B1 (cg-RX-API-DMAC7.html)
EP (1) EP1117404A1 (cg-RX-API-DMAC7.html)
JP (1) JP2002526409A (cg-RX-API-DMAC7.html)
AR (1) AR020681A1 (cg-RX-API-DMAC7.html)
AU (1) AU5998399A (cg-RX-API-DMAC7.html)
BR (1) BR9914254A (cg-RX-API-DMAC7.html)
CA (1) CA2346086A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000020002A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE437634T1 (de) * 2004-01-14 2009-08-15 Lavipharm Lab Inc Transdermale abgabevorrichtung für dihydropyridin-artige calcium-antagonisten mit 2 fettsäuren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
AU4807790A (en) * 1988-12-05 1990-06-26 Houston Biotechnology Incorporated Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
FR2642307A1 (fr) * 1989-01-27 1990-08-03 Corbiere Jerome Medicament pour le traitement des maladies degeneratives de la retine et notamment des maladies conditionnees genetiquement, et un procede pour leur obtention
JP3041923B2 (ja) * 1990-06-27 2000-05-15 藤沢薬品工業株式会社 ジヒドロピリジン化合物を含有する抗炎症および活性酸素産生抑制剤
US5691360A (en) * 1993-12-08 1997-11-25 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
CA2252962A1 (en) * 1996-04-26 1997-11-06 Fujisawa Pharmaceutical Co., Ltd. Peripheral circulation improvers for ophthalmic tissues containing dihydropyridines
JPH1072347A (ja) 1996-05-27 1998-03-17 Otsuka Pharmaceut Co Ltd 眼血管血流改善剤

Also Published As

Publication number Publication date
JP2002526409A (ja) 2002-08-20
EP1117404A1 (en) 2001-07-25
AR020681A1 (es) 2002-05-22
BR9914254A (pt) 2001-07-03
US6248759B1 (en) 2001-06-19
WO2000020002A1 (en) 2000-04-13
AU5998399A (en) 2000-04-26

Similar Documents

Publication Publication Date Title
EP0093380B1 (en) Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
US5863948A (en) Increasing aqueous humor outflow
EP2156833B1 (en) Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
CN114845718B (zh) 用于治疗与过度血管形成相关的眼部疾病的化合物
EP3643723B1 (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
CN108135737A (zh) 用于治疗翼状胬肉的组合物和方法
RU2414904C2 (ru) ЗАЩИТНОЕ СРЕДСТВО ДЛЯ НЕЙРОНА СЕТЧАТКИ, СОДЕРЖАЩЕЕ В КАЧЕСТВЕ АКТИВНОГО КОМПОНЕНТА ПРОИЗВОДНОЕ ПРОСТАГЛАНДИНА F2α
JP7801201B2 (ja) ヘテロシクリデンアセトアミド誘導体含有医薬
CN110787158B (zh) D609在制备预防和治疗视网膜损伤性疾病药物中的应用
WO1999038497A2 (en) Ophthalmic composition
KR20150032552A (ko) 치료 제제 및 치료 방법
HU215959B (hu) Eljárás 5-metil-izoxazol-4-karbonsav-anilideket vagy 2-hidroxi-etilidén ciano-ecetsav-anilideket tartalmazó, szembetegségek kezelésére helyileg alkalmazható gyógyszerkészítmények előállítására
US11717513B2 (en) Mirabegron for the treatment of retinal diseases
EP4197540A1 (en) Drug formulation containing sepetaprost
US6248759B1 (en) Method for treatment of light-injured retinal degeneration disease
KR980008226A (ko) 시각기능장애의 예방 및 치료제
EP0647445B1 (en) Composition for prophylaxis and treatment of myopia
JP2001519394A (ja) 緑内障の局所治療用フルナリジンの使用法
JP3066561B2 (ja) 近視予防・治療剤
US7910615B2 (en) Prophylactic or therapeutic agent for diabetic maculopathy
JPWO2005079792A1 (ja) 重症糖尿病網膜症の予防又は治療剤
WO2010056710A1 (en) Compositions and methods for treating eye diseases
CA1279015C (en) Increasing aqueous humor outflow
JP7197112B2 (ja) 水泡性角膜症治療用医薬組成物
JPWO2007100079A1 (ja) 三環性トリアゾロベンゾアゼピン誘導体を含有する、アレルギー性眼疾患またはアレルギー性鼻疾患の予防または治療剤

Legal Events

Date Code Title Description
FZDE Discontinued